L-028-2019
Agreement ID
L-028-2019
Lead IC
NIAID
Exclusivity
Exclusive
External Party
Ridgeback Biotherapeutics
Fiscal Year
2022
Territory
Worldwide
Execution Date
Effective Date
Export Date